About us
Our Company
Our Leadership
Precision Research
GPCRs in IO
Our innovative approach
Our Programs
Partnerships
Our Collaborations
Our Partners
News & Media
Press releases
News
Downloads
Opportunities
Partnering Opportunities
Career opportunities
Search on our website
Type Enter to start searching.
Pipeline
- page
Scroll to explore
Latest
Scroll back top
6 October 2022
Domain Therapeutics to present new data on its EP4R and CCR8 antagonists at 2022 SITC Annual Meetin...
Discover more
22 September 2022
Domain Therapeutics at Sachs Forum
Discover more
22 September 2022
Domain Therapeutics signs a research agreement with SYnAbs to discover therapeutic antibodies on GPC...
Discover more
28 June 2022
Domain Therapeutics receives a single digit multimillion development milestone payment from Merck fo...
Discover more
10 May 2022
Domain Therapeutics raises $42m Series A financing
Discover more
19 April 2022
Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GP...
Discover more
24 March 2022
Index égalité femme homme 2022
Discover more
10 March 2022
Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
Discover more
8 March 2022
Domain Therapeutics presents some of its talented women for Women International Day
Discover more
14 February 2022
Find Therapeutics, the Montreal-based company that Domain has contributed to launching, appoints Dr....
Discover more